Showing results (441-450 of 490) with videos related to

Sort By:
Pageof 49
Blood|November 15, 2021
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosisAdi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
The New England Journal of Medicine|May 7, 2020
Emapalumab in Children with Primary Hemophagocytic LymphohistiocytosisFranco Locatelli, Michael B Jordan, Carl Allen, et al.
Blood|July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Blood|April 18, 2019
Recommendations for the management of hemophagocytic lymphohistiocytosis in adultsPaul La Rosée, AnnaCarin Horne, Melissa Hines, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Elife|September 16, 2016
TP53 drives invasion through expression of its Δ133p53β variantGilles Gadea, Nikola Arsic, Kenneth Fernandes, et al.
Scientific Reports|March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient seriesMatthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood Advances|April 18, 2025
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patientsAdi Zoref-Lorenz, Jun Murakami, Ronit Gurion, et al.
Pageof 49